Status:
UNKNOWN
To Compare Intravitreal Clindamycin & Dexamethasone With Classic Treatment of Toxoplasmic Retinochoroiditis
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Conditions:
Chorioretinitis
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
Toxoplasmosis, an intra cellular parasite, is a very important cause of chorioretinitis. The goal of treatment is arresting multiplication of the parasite in its inflammatory active phase. In this stu...
Eligibility Criteria
Inclusion
- Patients with Toxoplasmic chorioretinitis
- Location of the lesion within zone I of the retina or a lesion greater than 2DD with 3+-4+ vitreous inflammation in zone II or III
- No allergic history to the used drugs
- No any other diseases
Exclusion
- Any allergic reaction to the used medications
- One eyed patients
- Partially treated patients
Key Trial Info
Start Date :
July 1 2005
Trial Type :
INTERVENTIONAL
End Date :
November 1 2008
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00372294
Start Date
July 1 2005
End Date
November 1 2008
Last Update
July 30 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ophthalmic Research Center
Tehran, Tehran Province, Iran, 16666